Simi Valley, CA, United States of America

Jeffrey Abel

This inventor holds 1 USPTO granted patent. Top assignee: Amgen Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jeffrey Abel. Retrieved from https://idiyas.com/inventor/jeffrey-abel-jimu2d06

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jeffrey Abel: Innovator in Protein Composition

Introduction

Jeffrey Abel is a notable inventor based in Simi Valley, CA. He has made significant contributions to the field of protein compositions, particularly through his innovative methods for preparing stable protein formulations. His work has implications for various applications in biotechnology and pharmaceuticals.

Latest Patents

Jeffrey Abel holds a patent titled "Methods for making stable protein compositions." This invention relates to methods for preparing stable buffered and buffer-free protein compositions. Additionally, it encompasses techniques for purifying proteins from one or more impurities. His patent demonstrates a commitment to advancing the science of protein stability and purification.

Career Highlights

Abel is currently employed at Amgen Inc., a leading biotechnology company known for its focus on innovative therapies. His role at Amgen allows him to apply his expertise in protein chemistry and contribute to the development of groundbreaking treatments.

Collaborations

Throughout his career, Jeffrey has collaborated with talented individuals such as William Callahan and Lorenzo Desantiago. These partnerships have likely enriched his work and fostered a collaborative environment for innovation.

Conclusion

In summary, Jeffrey Abel is a distinguished inventor whose work in protein compositions has the potential to impact the biotechnology industry significantly. His patent and collaborations reflect his dedication to advancing scientific knowledge and improving therapeutic solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…